Market Tracker

06/24 5:16pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.86
Delayed Data
As of Jun 24
 -0.34 / -5.48%
Today’s Change
2.80
Today|||52-Week Range
10.51
+16.04%
Year-to-Date

Today’s Trading

Previous close6.20
Today’s open5.80
Day’s range5.75 - 6.14
Volume4,034,218
Average volume (3 months)1,668,334
Market cap$620.1M
Dividend yield--
Data as of 4:00pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)+19.98%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book7.09

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...-0.94-5.18%
MNKDMannKind Corp+0.01+0.81%
INSMInsmed Inc-0.68-6.61%
ADROAduro Biotech Inc-0.83-7.59%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts